Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs (Review).

Autor: Jiang, Nan1,2, Lin, Jing-Jing1,2, Wang, Jun3, Zhang, Bei-Ning1,4, Li, Ao1,4, Chen, Zheng-Yang1,2, Guo, Song1,2, Li, Bin-Bin1,4, Duan, Yu-Zhong1, Yan, Ru-Yi4,5, Yan, Hong-Feng1, Fu, Xiao-Yan1, Zhou, Jin-Lian5, Yang, He-Ming1, Cui, Yan1 dryancui@163.com
Zdroj: Experimental & Therapeutic Medicine. Sep2018, Vol. 16 Issue 3, p2183-2192. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje